Overview

Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis

Status:
Completed

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy, safety and tolerability of topical 10% terbinafine hydrogen chloride applied daily versus 5% amorolfine nail lacquer applied twice a week in patients with mild to moderate toenail onychomycosis, for a total treatment duration of 48 weeks.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Amorolfine
Terbinafine